Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05099068Unknown
Open-label trial (3 arms), sponsored by Centre Léon Bérard. Primary endpoints: Number of patients with meaningful molecular genetic alterations on tumor sample at 4 years, Number of patients with meaningful molecular genetic alterations on circulating tumour DNA (ctDNA) at 4 years and 4 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05099068.